|
Valoración de DCF de Resmed Inc. (RMD)
US | Healthcare | Medical - Instruments & Supplies | NYSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
ResMed Inc. (RMD) Bundle
¡Explore las perspectivas financieras de ResMed Inc. (RMD) con nuestra calculadora DCF fácil de usar! Ingrese sus suposiciones con respecto al crecimiento, los márgenes y los gastos para calcular el valor intrínseco de ResMed Inc. (RMD) e informar su estrategia de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,957.0 | 3,196.8 | 3,578.1 | 4,223.0 | 4,685.3 | 5,259.3 | 5,903.7 | 6,627.0 | 7,438.9 | 8,350.3 |
| Revenue Growth, % | 0 | 8.11 | 11.93 | 18.02 | 10.95 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 |
| EBITDA | 990.4 | 1,099.2 | 1,176.6 | 1,358.8 | 1,533.5 | 1,742.6 | 1,956.1 | 2,195.8 | 2,464.8 | 2,766.8 |
| EBITDA, % | 33.49 | 34.38 | 32.88 | 32.18 | 32.73 | 33.13 | 33.13 | 33.13 | 33.13 | 33.13 |
| Depreciation | 181.4 | 191.5 | 193.8 | 196.5 | 216.2 | 282.0 | 316.6 | 355.3 | 398.9 | 447.7 |
| Depreciation, % | 6.13 | 5.99 | 5.42 | 4.65 | 4.61 | 5.36 | 5.36 | 5.36 | 5.36 | 5.36 |
| EBIT | 809.1 | 907.7 | 982.8 | 1,162.3 | 1,317.3 | 1,460.6 | 1,639.6 | 1,840.4 | 2,065.9 | 2,319.0 |
| EBIT, % | 27.36 | 28.39 | 27.47 | 27.52 | 28.12 | 27.77 | 27.77 | 27.77 | 27.77 | 27.77 |
| Total Cash | 463.2 | 295.3 | 273.7 | 227.9 | 238.4 | 452.6 | 508.1 | 570.4 | 640.2 | 718.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 484.1 | 614.3 | 576.0 | 704.9 | 837.3 | 907.2 | 1,018.3 | 1,143.1 | 1,283.2 | 1,440.4 |
| Account Receivables, % | 16.37 | 19.22 | 16.1 | 16.69 | 17.87 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
| Inventories | 416.9 | 457.0 | 743.9 | 998.0 | 822.3 | 950.6 | 1,067.0 | 1,197.7 | 1,344.5 | 1,509.2 |
| Inventories, % | 14.1 | 14.3 | 20.79 | 23.63 | 17.55 | 18.07 | 18.07 | 18.07 | 18.07 | 18.07 |
| Accounts Payable | 135.8 | 138.0 | 159.2 | 150.8 | 237.7 | 231.4 | 259.8 | 291.6 | 327.4 | 367.5 |
| Accounts Payable, % | 4.59 | 4.32 | 4.45 | 3.57 | 5.07 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 |
| Capital Expenditure | -105.9 | -116.8 | -156.0 | -134.0 | -114.9 | -181.2 | -203.4 | -228.3 | -256.2 | -287.6 |
| Capital Expenditure, % | -3.58 | -3.65 | -4.36 | -3.17 | -2.45 | -3.44 | -3.44 | -3.44 | -3.44 | -3.44 |
| Tax Rate, % | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 | 19.28 |
| EBITAT | 686.1 | 487.4 | 797.5 | 946.9 | 1,063.4 | 1,115.4 | 1,252.1 | 1,405.5 | 1,577.7 | 1,771.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -3.7 | 394.0 | 608.1 | 617.9 | 1,295.1 | 1,011.8 | 1,166.1 | 1,308.9 | 1,469.3 | 1,649.3 |
| WACC, % | 7.61 | 7.57 | 7.61 | 7.61 | 7.61 | 7.6 | 7.6 | 7.6 | 7.6 | 7.6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 5,237.7 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 1,715 | |||||||||
| Terminal Value | 47,633 | |||||||||
| Present Terminal Value | 33,024 | |||||||||
| Enterprise Value | 38,262 | |||||||||
| Net Debt | 636 | |||||||||
| Equity Value | 37,626 | |||||||||
| Diluted Shares Outstanding, MM | 148 | |||||||||
| Equity Value Per Share | 255.00 |
What You Will Get
- Real RMD Financial Data: Pre-filled with ResMed’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See ResMed’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- 🔍 Real-Life RMD Financials: Pre-filled historical and projected data for ResMed Inc. (RMD).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate ResMed’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize ResMed’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Open the Template: Download and open the Excel file containing ResMed Inc.'s (RMD) preloaded data.
- 2. Edit Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
- 4. Test Scenarios: Evaluate various forecasts to analyze different valuation outcomes for ResMed Inc. (RMD).
- 5. Use with Confidence: Present professional valuation insights to inform your investment decisions regarding ResMed Inc. (RMD).
Why Choose This Calculator for ResMed Inc. (RMD)?
- Precise Information: Authentic ResMed financials guarantee trustworthy valuation outcomes.
- Tailorable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Efficiency Boost: Ready-made calculations save you the effort of starting from the ground up.
- Expert-Level Tool: Crafted for investors, analysts, and consultants in the healthcare sector.
- Easy to Use: User-friendly design and clear instructions ensure accessibility for everyone.
Who Should Use This Product?
- Healthcare Professionals: Develop comprehensive valuation models for assessing ResMed Inc. (RMD) investments.
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Financial Consultants: Deliver precise valuation insights related to ResMed Inc. (RMD) for client advisement.
- Students and Instructors: Utilize real-world financial data to enhance learning and practice in financial modeling.
- Market Analysts: Gain insights into how healthcare technology companies like ResMed Inc. (RMD) are valued in the investment landscape.
What the ResMed Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for ResMed Inc. (RMD).
- Real-World Data: ResMed’s historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into ResMed's performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to ResMed Inc. (RMD).
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for decision-making.